IV Iron Treatment of Restless Legs Syndrome
NCT02484768
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
as per GCP sponsor/company decision
Conditions
Restless Legs Syndrome
Interventions
DRUG:
Iron isomaltoside 1000
DRUG:
Sodium Chloride 0.9%
Sponsor
Pharmacosmos A/S
Collaborators
[object Object]
[object Object]